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Doctors pour drugs, 
of ~hich they kno~ very 2itt2e, 
into patients, 
of ~ho~ they kno~ even 1ess. 
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ABSTRACT 
The aging process is associated with disease states that may 
be painful, disabling and life-threatening. Elderly patients 
frequently have more than one disorder and appropriate 
pharmacotherapy may result in polypharmacy (treatment with 
multiple drugs). This situation, combined with age-related 
alterations in the handling of and sensitivity to drugs, 
predisposes older patients to adverse drug reactions <ADR's). 
This study was undertaken to assess the actual risks and 
potential benefits of long-term polypharmacy in the 
management of elderly hospital out-patients. A particular 
aim was to get some indication of whether or not 
polypharmacy was justifiable in the study population. 
Accordingly the medical records of 132 ambulatory patients, 
70 years of age and over, who had been attending the general 
out-patient department of a large teaching hospital for a 
period of twelve months or longer, were retrospectively 
examined. 
medication, 
The patient's age, diagnoses, prescribed 
ADR's and clinical therapeutic benefit were 
assessed, recorded and analyzed. 
The average patient age in the sample studied was 77,6 years. 
71% of the sample were females. 419 disorders were 
identified, giving an average of 3,17 per patient. 603 drugs 
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were prescribed in total, giving an average of 4, 57 per 
patient. There was no statistically significant association 
between increasing age and the number of diagnoses per 
patient or the number of drugs prescribed. Medication was 
felt to be therapeutically effective in 63% of the patients, 
whilst an ADR was noted in 14% of the sample. There was no 
statistically significant difference in the age, number of 
diseases or number of drugs prescribed between the total 
group, the ADR group and the non-ADR group. These parameters 
were therefore not useful in identifying those patients more 
likely to experience an ADR. 
The apparent effectiveness of the medication prescribed and 
the relatively low incidence of ADR' s in the group studied 
suggests that appropriate and judicious multiple drug therapy 
can benefit many elderly ambulatory patients and therefore 
polypharmacy could be regarded as permissible in this 
context. Apart from these observations, this dissertation 
also includes recommendations on ways to minimize the 
incidence of ADRs in the elderly, and areas for ongoing 
research in this field are identified. 
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CHAPTER ONE 
DRUGS AND THE ELDERLY 
As people age they tend to acquire condi ti ans which can be 
painful, disabling and even life-threatening. In attempting 
ta help alder people, health professionals often prescribe 
medication which may be bath efficacious and safe, but at 
other times may do mare harm than goad. Epidemiological 
data and pharmacological studies in the aged have shown that 
drugs are used more frequently in the elderly, whilst their 
therapeutic and adverse reaction profile tends ta differ from 
that found in younger patients. 
Pharmacolcgical considerations 
The nature of the primary aging process has yet ta be 
defined, but it is accompanied by physiological changes and 
age-related diseases. 1 These in turn may profoundly alter 
patient response to therapy, but this is difficult ta predict 
due to the increase in interpatient variability that occurs 
with age. 2 Associated alterations in the absorption, 
distribution, metabolism and 
<pharmacokinetics) are among 








contribute ta the potential toxicity of certain drugs in the 
elderly. 3 
The absorption of drugs in the elderly may be influenced by 
decreased gastric acid production, delayed gastric emptying, 
diminished splanchnic blood flow, and reduced gastro-
intestinal mucosal cell mass. These changes however appear 
ta be of little clinical significance.' 
The distribution of drugs can be altered as a result of the 
reduced lean body :mass, reduced total body water, and 
increased total body fat found in the elderly. Thus, 
generally speaking, the distribution of hydrophilic drugs 
(such as paracetamol) tends to decrease in the elderly, 
whilst that of lipaphilic drugs <such as diazepam) tends ta 
increase. This can result in clinically important changes in 
drug half-lives and serum drug concentrations.a 
Another important determinant of drug distribution in the 
elderly is a reduced serum albumin concentration. a Mild 
reductions in serum albumin may be present in healthy older 
patients, but those who are chronically ill or malnourished 
may have substantial reductions. These changes are 
important when highly protein-bound drugs are used, as a low 
albumin decreases the number of available binding sites which 
in turn increases the amount of free <active) drug. Many 
drugs <such as warfarin, nansteraidal anti-inflammatory 













considerable potential for interaction between drugs due to 
the displacement of one by another, leading to increased 
serum concentration of the displaced free drug and resultant 
toxicity. The acidic drugs are the agents most involved in 
such displacement reactions. 
Age-related changes in liver function may affect the 
metabolism of certain drugs. 4 Liver mass falls with 
advancing age, and liver blood flow may also decrease with 
increasing age. For orally administered lipid soluble drugs 
with a high hepatic elimination rate <such as propanolol and 
verapamil), these factors may result in reduced first pass 
metabolism and thus increased bio-availibility. Hepatic 
biotransformation reactions such as oxidation, reduction, or 
hydrolysis <Phase I) may be significantly impaired in older 
patients. For certain of the hepatically metabolized 
benzodiazepines, notably diazepam and chlordiazepoxide, 
impairment of oxidative reactions appears to be greatest in 
elderly men. Hepatic conjugation reactions <Phase I I) do 
not appear to alter significantly with advancing age. 
The contribution of aging to altered hepatic drug metabolism 
is in any event confounded by other variables such as inter-
individual genetic variation, nutritional and vitamin status, 
caffeine and cigarette consumption, and cardiac output. 
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An important phar:macokinetic cause of adverse
 drug reactions 
in the elderly is impaired renal function. 
5 Renal plasma 
flow decreases gradually from 600 ml/min in th
e second decade 
af life to 300 ml/min in the eighth decade
, and there are 
also reductions in the glomerular filtration 
rate. However, 
wide variation in the rates af decline 
with aging in 
individual persons is seen. Ren
al circulation and function 
is furthermore often particularly s
ensitive in the elderly 
ta extrarenal factors such as disease a
nd drugs, thus 
compounding the above changes. Impaired 
renal function 
results in impaired elimination af those dr
ugs excreted by 
glamerular filtration <such as digaxin and 
cimetidine) and 
those excreted by tubular secretion <such as 
the penicillins, 
cephalosporins and aminoglycosides). 
The ability to measure certain drug leve
ls has made it 
relatively easy to study drug disposition 
in the elderly. 
Of equal importance are the effects of a giv
en concentration 
af drug at its site of action <phar:macodynam
ics) but this has 
been less studied in man because of th
e considerable 
difficulties involved. However it has been
 shown that the 
elderly are more resistant to the effects of 
isoprenaline and 
propanolol and more sensitive to ce
rtain of the 
benzodiazepines and warfarin.
3 Much additional research is 
needed to further characterize age-related 
alterations in 
pharmacodynamics. 
DRUGS ANO THE ELDERLY 
4 
Epidemiological data 
It has been esti:mated that over 15 million elderly Americans 
have one or more chronic illnesses, this presumably 
accounting in part for the fact that in the U.S.A. 25 to 30 
percent of total dr'.Jg expenditure represents medication for 
the elderly, who make up only 11 percent of the population. 7 
Although corresponding data for the situation in South Africa 
are not available•, the number of elderly in this country 
should increase dramatically in the next decade. 9 
Recent data from the United States indicates that 12 to 17 
percent of all hospital admissions of elderly patients are 
due to adverse drug effects, which is three to four times the 
rate for al 1 other patients. 1 0 The cost of adverse drug 
reactions in the elderly may well approach three billion 
dollars a year. 10 A study in the United Kingdom involving 
2 000 admissions to 42 Geriatric Uni ts has shown that about 
ten percent of all patients were admitted solely or partly 
because of adverse drug reactions. 1 1 As far as is known, 
there has only been one report from South Africa of hospital 
admissions related to adverse drug reactions <ADRs>. 12 The 
study found.that 4,6% of all admissions were ADR related, and 
all the affected patients were over 50 years of age, with a 
median age of 73 years. Other data suggests that adverse 
reactions to drugs increase progressively from about thirty 
years of age onwards, with a particularly noticeable increase 
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after the age of 65, 13 and the frequency of adverse drug 
effects among community-living elderly may be as high as 40 
percent. 14 
Although the above-mentioned studies provide reasons for 
concern about the problem of ADRs among the elderly, it has 
been suggested that many such studies have either 
methodological weaknesses or are prone to misinter-
pretation. 16 Another report has stated that "the data on ADRs 
are incomplete, unrepresentative, uncontrolled, and lacking 
in operational criteria for identifying ADRs." 16 The authors 
were particularly concerned about the fact that the great 
majority of the available reports are based on hospitalised 
patients in acute medical wards. Such patients may differ 
considerably from the ambulatory patients who account for the 
bulk of medicinal use. 
It was with these factors in mind that the study described in 
this report was undertaken. The purpose and methodology are 
described in the following chapter. 
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CHAPTER TWO 
AN OUTPATIENT SURVEY 
AT 
GROOTE SCHUUR HOSPITAL 
Despite the fact that the elderly are an at-risk group for 
adverse drug reactions, they are frequently treated with 
multiple medications for multiple ailments, resulting in a 
situation which has become known as polypharmacy. 17 This is 
perceived as a problem by many health care professionals and 
administrators, primarily because of the possible morbidity, 
mortality, and resultant financial costs that may occur when 
multiple drug therapy is used. However it may also be a 
necessity, given the variety and number of symptomatic 
disorders that the elderly are prone to, and the problem of 
polypharmacy may therefore only be of relevance where 
unnecessary or inappropriate drugs are prescribed, or where 
indicated drugs are used incorrectly, or where the prescriber 
does not watch for toxicity. It has been stated that 
"polypharmacy (in the elderly> is not only inevitable, but to 
insist on its rigid control to predetermined numbers of items 
by arbitrary decision could be a negation of good medicine 
and inhumane. " 1 e 
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The study described in this dissertation was undertaken to 
assess whether, in the typical setting provided by an 
outpatient clinic of a major teaching hospital, combinations 
of drugs could be prescribed to the elderly over a reasonable 
period of time without the emergence of an unduly high 
incidence of side-effects. Furthermore, in order to properly 
evaluate polypharmacy, an attempt was made to simultaneously 
aseess the efficacy of the drugs being used. Falb has stated 
that "a risk-benefit assessment has to be made by the 
physician in prescribing any medicine. It is a challenge to 
all concerned that the physician is fully informed as to both 
sides of that equation." 19 
Methods 
A consecutive series of the medical records of patients aged 
70 and over who had attended the white General Out-patient 
Department (GOPD) at Groote Schuur Hospital from 1 June 1982 
onwards was used in this study. At the time of the study, 
many elderly pensioners attended GOPD for initial and ongoing 
assessment and medication. The medical staff of GOPD 
consisted mainly of senior General Practitioners. It was 
felt that this situation was one in which polypharmacy in the 
elderly could be studied. 
The patient population was considered to be homogenous as. 
regards its general characteristics, and for this reason the 
AN OUTPATIENT SURVEY AT GROOTE SCHUUR HOSPITAL 8 
consecutive series used was felt to be representative of the 
population studied and so no further randomization was done. 
As this study was concerned with the efficacy and safety of 
long-term polypharmacy, only the records of those patients 
who had been attending GOPD for a period of 12 months or 
longer were used. However, in screening the records of 
patients who had been attending for less than twelve months, 
there was no evidence that these patients experienced a 
higher or lower incidence of side-effects than those who had 
been attending for longer. In all, during the time available 
for the study, the records of 132 patients who fulfilled the 
above criteria were retrospectively examined and analysed by 
the author. A formatted data collection sheet was used 






Patient age and sex; 
Number of disorders being treated; 
Drugs prescribed for each patient, and dosage; 
Length of time (in months) that the patient had been 
on the identical prescription; 
AN OUTPATIENT SURVEY AT GROOTE SCHUUR HOSPITAL 9 
v) If there had been any stop or change in medication 
since the start of the patient's attendance at GOPD, 
the reasan/s far this were noted: e.g. emergence of 
side-effects, therapeutic failure, appearance of an 
additional disorder; 
vi) If side-effects had been noted in Cv), the drugs 
responsible were recorded and also any possible 
interaction between drugs; 
vii) Any indication in the medical record that the current 
prescription appeared effective in controlling the 
symptoms or natural history of the disorder being 
treated. This is explained in more detail on page 13. 
Limitations of the methods used 
Data collection in classes Ci) ta Civ) was done by simply 
recording available data from the patient's hospital folder. 
However at least one study20 has shown that there are often 
considerable discrepancies between the number and types of 
drugs recorded in the hospital record and the drugs that the 
patient is actually taking. In that study, a review of the 
actual medication being taken by the patient showed that 16 
per cent were making same major error or omission when the 
drugs were compared with those listed in their hospital file. 
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The other problem in a retrospective study of this nature is 
that parameters such as drug efficacy or side-effects may not 
be recorded as such in the patient's folder and thus may have 
to be assessed by the observer from the clinical ~ates. This 
is subject ta observer bias and difficulties and errors in 
interpretation. 21 This kind of problem was illustrated in 
one study of presumably healthy individuals who were not on 
medication, where 81 per cent of respondents reported having 
experienced symptoms during the 72 hour period before 
questioning that could have been classified as adverse drug 
reactions. 22 The World Health Organisation's definition of an 
adverse drug reaction <ADR) as: "Any response to a drug which 
is noxious and unintended and which occurs in doses in man 
for prophylaxis, diagnosis, or therapy" requires observer 
interpretation of naxiousness. 23 
The other problem in the assessment of ADR's is the 
establishment of a causal role between an adverse event and 
a drug, 
has led 
particularly in the presence of palyphar:macy. This 
to the redefinition of an ADR as "an undesirable 
clinical manifestation consequent to and caused by the 
administration cf a given drug" 24 , and since this definition 
includes the concepts of noxiousness and causality, it was 
used in this study. However defining causality in the 
clinical setting is largely dependent on an experienced 
observer, and in an attempt to improve validity and 
reproducibilty, an algorithm has been developed to assess the 
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causal association between drug and event. 24 This algorithm 
rates the probability of causality by incorporating 
general experience with the such as the previous 
alternative aetiological 











rechallenge. However at least one study has concluded that, 
when compared to informal assessment by one observer al one, 
the use of such algorithms in drug surveillance programs 
"does not improve the uniform! ty Car validi_~y) of adverse 
drug reaction assessments." 26 
Despite difficulties with methods of causality assessment for 
suspected ADRs, 26 the author's experience in presri bing for 
many elderly patients has been that frequently patients give 
remarkably good accounts of untoward symptoms that they can 
clearly attribute to a given drug. The ADR's recorded in our 
study were either spontaneously reported by the patient, or 
noted by the attending physician in assessing a symptom or 
physical sign. 
The assessment of efficacy is in many ways subject to similar 
diificul ties that have been discussed above regarding the 
detection and interpretation of ADR's. Spilker has stated 
that "many efficacy measures yield less objective data than 
one would ideally like to obtain. Subjective measures often 
depend on clinical evaluation or examination of the patient 
or on the investigator's interpretation of the patient's 
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statements. Under these circumstances, it is generally 
desirable to have the same investigator perform the 
nonobjective measures throughout the study." 27 
As this study was retrospective, use had to be made of 
subjective measures of efficacy, as assessed by the author 
when reviewing the clinical records. Treatment was judged 
as effective if follow-up notes contained a statement such as 
"feels much better", or if the physical signs for which the 
medication was being given had responded favourably (e.g. 
reduction in blood pressure). Treatment was regarded as 
ineffective if the original problem had persisted unchanged. 
If there was no evidence either way, efficacy was recorded as 
uncertain. The assessment of efficacy in this study was thus 
problematic, mainly because of the potential for observer 
bias on the part of the patient, the attending physician and 
the author. It was nevertheless undertaken as part of the 
overall analysis of polypharmacy in the study group, whilst 
the findings have to be interpreted with the above 
limitations in mind. 
Data analysis 
Data from the data collection sheets was entered into the 
Cracker-II graphical spreadsheet28 and this was processed on 
an Amstrad PCW8256. The results are detailed in the 
following chapter. 
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CHAPTER THREE 
RESULTS 
Age and sex distribution 
The study group of 132 patients consisted of 94 females and 
38 males, comprising 72 and 28 percent of the total sample 
respectively. 
years, with a 
The average age of the whole group was 77, 6 
standard deviation (SD)of 5,3 years. The 
female group had an average age of 77, 7 years <SD of 4, 9), 
while the average age of males was 77,1 years (SD of 6,1). 
Of the 132 patients, 19 were noted to have experienced an 
adverse drug reaction <ADR). No patient had more than a 
single ADR. The average age of the ADR group was 76,9 years 
<SD of 4, 12) and the average age of the non-ADR group was 
77,7 years <SD of 5,8). 
Figure 3. 1 (shown overleaf) is a graphic representation of 
the age and sex characteristics of the total 
population, and the age distribution of the ADR group. 
study 
This 
latter group was not subdivided into male and female, as only 














































































































Disease characteristics of the study group 
A total of 419 conditions were identified in the study group, 
this giving an average of 3,2 problems per patient. The age 
and sex distribution of these problems is shown in Table 3.1. 
Table 3,1; Age and sex distribution of problems 
Age group 













A graphic representation of the relative contribution of the 
different diagnostic classes to the total number of problems 
is shown overleaf in Figure 3.2, and a more detailed 
numerical analysis follows in Table 3.2. 
Figure 3. 3 is a histogram showing the average number of 
diseases in each age group from 70 to 94 years. Due to lesser 
numbers of old patients, 85 to 89 year olds were grouped 
together, as were the 90 to 94 year olds. Spearman's Rank 
Correlation Coefficient29 showed no significant association 






































































Congestive Cardiac Failure 
























































































































































It was assumed that patients were taking their medication as 
prescribed. A graph of the numbers of drugs prescribed to 
different sub-groups of patients is shown in Figure 3.4. 
A total of 603 drugs were prescribed, giving an average of 
4,6 drugs per patient <SD= 1,6), and a ratio of 1,44 drugs 
per condition being treated. Females received an average of 
4,7 drugs <SD= 1,6) and :males an average of 4,3 <SD= 1,7). 
The ADR group received an average of 4, 3 drugs per patient 
<SD = 1, 6). Thus the ADR group received on average fewer 
drugs than the total group, although this difference was not 
statistically significant. A subgroup of 32 patients who had 
been taking their medication unchanged for a p'eriod of 12 
months or longer without experiencing any recorded adverse 
reactions, received an average of 3,8 items/patient 
Figure 3.5. shows the average number of drugs prescribed in 
each age group. Spearma.n's Rank Correlation Coefficient
29 
indicated that there was no significant association between 
age and the number of drugs prescribed <r. = 0,0421) 
A graphic representation of the relative amounts prescribed 
in the different drug classes is shown in Figure 3.6, with a 
more detailed description in Table 3. 3. The major drug 
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Table 3.3: Drugs prescribed <603 drugs> 
DRUG FREQUENCY 
Cardiovascular System(including diuretics). 
Amiloride,hydrochlorothiazide 43 
Cyclopenthiazide 29 
Fu rose mi de 23 







Glyceryl trinitrate 14 
Isosorbide dinitrate 22 
Indapamide 2 
















Castro-intestinal Tract Total:63 
Antacids (various) 28 
Cimetidine 2 
Sucralfate 1 
Stimulant laxatives 17 
Bulk-forming drugs 11 
Hyoscine butylbromide 4 













































*includes artificial sweeteners, decongestants, urinary antiseptics, and 
short courses of antibiotics 
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Table 3,4: The most frequently prescribed classes of drugs 
DRUG FREQUENCY 
1. Diuretics 95 
2. Antihypertensives* 50 
3. Benzodiazepines 49 
4. Nonsteroidal 
anti-inflammatory drugs 44 
5. Coronary vasodilatorsT 43 
6. Analgesics 42 
7. Antacids 28 
8. Laxatives 28 
9. Bronchodilators 28 
10.Digoxin 26 
11.Vitamins 24 
12.Potassium supplements 19 





























* excluding diuretics, including beta-blockers 
.,. both nitrates and calcium-channel blockers 
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Adverse drug reactions 
Adverse drug reactions were noted in 19 patients, and these 
are detailed in Table 3.5. As far as could be ascertained, 
none were severe enough to require admission, although in all 
instances the offending drug was discontinued. 
Table 3,5; Adverse drug reactions 




2 daily Muscle 
cramps 
Furosemide 80 mg daily 
Beta Blockers 
Oxprenolol 80 mg b.d. 
Atenolol 50 mg daily 









Centrally acting antihypertensive agents 
Methyldopa 250 mg b.d. Postural 
hypotension 
Cardiac glycosides 
Digoxin 0,25 mg daily Nausea and 
vomiting 
Non-steroidal anti-infla111I11atory drugs 
Diclophenac 25 mg t.d.s. Dyspepsia 
Indomethacin 25 mg t.d.s. Dyspepsia 
























-------------------------------------------------------------*Adverse reactions as a percentage of total prescriptions for the drug 
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Table 3.6 shows a comparison between the total group, the ADR 
group and the non-ADR group in respect of age, diseases and 
number of drugs. Inspection of the averages and their 
associated standard error shows overlap between all three 
groups for each of the above parameters. There is therefore 
no statistically significant difference between the three 
groups as regards age, diseases detected or number of drugs 
prescribed. 30 
Table 3.6: Comparison of the total, the non-ADR 
and the ADR groups 
•• TOTAL GROUP ff AGE DISEASES DRUGS (132 patients) 
TOTALS: 10237 419 603 
AVERAGE: 77.55 3. 17 4.57 
VARIANCE: 27.94 1. 85 2.58 
STD DEV: 5.29 1. 36 1. 61 
STANDARD ERROR: 0.46 0.15 0.14 
Females:94 
FEMALE AVERAGE: 77.73 3.29 4.68 FEMALE STD DEV: 4.93 1. 42 1. 58 Males:38 
MALE AVERAGE: 77.11 2.89 4.29 
MALE STD DEV: 6. 14 1. 18 1. 66 
•• NON-ADR GROUP•• <113 patients) 
TOTALS: 8776 352 522 
AVERAGE: 77.66 3.12 4.62 VARIANCE: 29.87 1. 60 2.59 
STD DEV: 5.47 1. 27 1. 61 STANDARD ERROR: 0.51 0.12 0.15 
•• ADR GROUP•• (19 patients) 




Using criteria of efficacy as outlined on page 13, the 
prescribed drugs were assessed as being effective in 83 
patients, or 63 % of the total sample. 57% of females and 76% 
of males appeared to benefit from treatment. In 44 patients 
(33% of total) it was not clear whether they benefitted: 37% 
of females and 24% of males were in this group. 5 patients 
(4% of total) appear not to have benefitted: all these 
patients were female and comprised 5% of all females. 
In the ADR subgroup, 11 patients (58% of the ADR group) were 
assessed as having benef i tted from their treatment, either 
unti 1 or despite the appearance of a side-effect. In the 
remaining 42% of this group efficacy was uncertain, but none 
of these patients appear to have shown no benefit from 
therapy. 
The data on drug efficacy appears graphically in Figure 3.7 
In a subgroup of 32 patients who had been on unaltered 
medication for at least twelve months, and who had not 
experienced any adverse reaction whi 1st on this medication, 
treatment was assessed as having a beneficial effect in 81% 
of these patients, and was of uncertain effectiveness in the 
remaining 19%. The drugs that these patients were on are 

































































































Table 3.7: Well tolerated drugs in a stable sub-group 
The following drugs, in the dosages indicated, were 
identified as being well tolerated in the thirty-two patients 
who had been on unaltered prescriptions for at least twelve 











0,125 mg daily 
160 mg daily 
100 - 200 mg daily 
30 - 60 mg daily 
10 - 80 mg daily 
0,5 mg p.r.n. 
40 - 120 mg daily 
40 mg twice weekly 





2 - 6 tabs daily 
50 nig daily 
1 - 2 daily 
1 - 2 daily 







1 - 3 tabs daily 
500 - 750 mg daily 
5 mg b. d. 






































Hi scel 1 aneous 
Thyroxine sodium 
Prednisone 
Vitamins (4 preparations) 
RESULTS 
120 - 180 mg t. d. s. 
1 nocte 
2 - 8 puffs daily 
2 - 12 mg daily 
2 nocte 
400 mg nocte 
7,5 - 22,5 mg nocte 
10 mls daily 
various 
30 mg daily 
10 -30 mg daily 
2 - 10 mg daily 
5 mg daily 
10 - 25 mg daily 
200 mg nocte 
0,2 mg daily 
























The study described in this dissertation was undertaken in 
order to establish whether the theoretical limitations to 
effective long-term palypharmacy in the elderly resulted in 
recorded morbidity in a group of elderly outpatients. The 
findings of this study have ta be interpreted in the context 
of the type of patients seen at a general outpatient 
department, from which group a relatively small sample was 
drawn. Data from the sample studied suggests that poly-
pharmacy is generally well tolerated and benefits the 
majority of patients. 
This conclusion is based on the fact that overall, 63% of 
patients were assessed as having benefi tted symptomatically 
from the medication prescribed, whilst in only 4% was there 
lack of efficacy; the remainder being uncertain. Thus, 
whilst well aver half of the patients appeared to benefit 
· from their treatment, only 14,47. of the patient sample 
experienced recorded adverse reactions, all of which were 
relative!y minor and were relieved by stopping or altering 
the offending medication. These results suggest that where 
multiple medication for multiple ailments is required, it is 
DISCUSSION 34 
generally likely to be of symptomatic benefit to the patient, 
and therefore should not be withheld on mainly theoretical 
grounds. This is in accordance with current medical practice. 




















suggests that, in patients over the· age of 70 years, these 
parameters are not predictors of the likelihood of an ADR. 
Comparison with other similar studies 
A search of the available literature has not revealed any 
study that attempts to assess the effectiveness of multiple 
medication prescribed to the elderly in the outpatient 
setting, whilst only two studies have been found which deal 
with the overall incidence of adverse drug reactions in 
ambulatory older patients. 
Klein et. al. 31 used telephonic interviews in a randomly 
selected group of 299 medical outpatients to investigate how 
often these patients linked untoward symptoms with their 
medication. 107 of their patients were 65 years and over, 
and in these patients, who were prescribed an average of 2,9 
medications each, the mean number of side-effects reported 
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was 0,37 per person, compared to 0,14 in our study. However 
the study methodologies are not comparable, as Klein's method 
used direct leading questions which covered a range of 
possible side-effects and could conceivably have resulted in 
an aver-reporting of non-specific symptoms that in fact were 
not causally related ta medication use. 
In a recent in-home survey32 of 155 ambulatory elderly 
patients with a mean age of 71,6 years Cvs 76,3 in our 
study), the average reported number of medical problems was 
3,8 per person <vs 3,2) and the average number of prescribed 
drugs being taken was 4,5 per person (vs 4,6). A history of 
adverse or allergic reactions to one or more drugs was common 
and was reported by 29, 1% of. respondents. Aspirins were the 
most common offenders and accounted far 13 % of the adverse 
effects. These aspirins appear to have been non-
prescription medication, and were acquired by the patients as 
over the counter drug$ <OTC's). Our study did not assess 
OTC's, and no aspirin side-effects were noted in our sample. 
If the adverse reactions ta aspirin in the above series are 
not considered, there remains a 16, 1% incidence of side-
effects, which is comparable to the 14, 4% incidence in our 
se.ries. Their list of commonly found drugs was similar in 
certain respects ta ours: 48% <vs 72%) of their patients were 
on diuretics, 17% <vs 14%) on potassium supplements, 36% <vs 
21%) on laxatives, and 33% (vs 21%) on antacids. 
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Discussion of specific classes of dru~s 
The findings of our study support the view that polypharmacy 
can benefit ambulatory elderly patients, and therefore what 
is needed is not an empirical reduction in the number of 
items prescribed, but rather skilled and knowledgeable 
prescribing practices. Those who presribe for elderly 
patients should fully appreciate that the use of any drug is 
governed by a consideration of its indications and its likely 
therapeutic index in a given patient, and that the assessment 
of this is often more difficult in the older patient because 
of the increased inter-individual variability for some 
parameters that occurs with advancing age, 73 and also because 
of the altered presentation of some disorders in the 
elderly. 74 Other factors such as patient compliance and the 
cost of medication must also be considered when the 
clinician is contemplating multiple drug therapy. 
The sample size used in this study is too small to draw 
definitive conclusions about drugs or dosages that should be 
avoided in the elderly, 33 but the agents that were noted to 
cause side-effects in this study will be detailed further 
below with reference to other reports of their potential 
toxic! ty in the elderly. In this study, a total of 607 
items were prescribed, 19 of which caused side-effects. 
These 19 items were however confined to only 5 classes of 
drugs, which will now be dealt with in turn. 
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DIURETICS 
The diuretics were the most frequently used class of drugs in 
this study, with 71,9 % of our patients receiving diuretics. 
Other studies have also shown that diuretics are the most 
frequently prescribed drugs in the elderly, 31 • 32 • 3 ' • 315 and 
this presumably reflects the high incidence of cardiovascular 
problems in the elderly, with hypertension and congestive 
cardiac failure being the two most common disorders treated 
in our study. Possibly reflecting this frequent use, 
diuretics were the most common cause of side-effects in our 
study, resulting in six reports of muscle cramps; three from 
furosemide and three from an amiloride/hydro-chlorothiazide 
combination. Although serum electrolyte levels were not 
checked in these 
was responsible 
pat i en ts, it 
for the 
is probable that hypokalemia 
muscle cramps. Electrolyte 
abnormalities, notably hypokalemia, are well recognized 
side-effects of both loop and thiazide diuretics. 36 • 37 ·The 
elderly are at particularly high risk for hypokalemia, as 
aging is associated with a reduced potassium intake. 13 
It has been suggested that diuretic induced potassium 
depletion might predispose to fatal cardiac arrythmias in 
certain patients prone to such arrythmias. 38 Hypokalemia can 
also potentiate digoxin toxicity, which is a problem that 
will be discussed further below. 
been noted with diuretics, 
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Other problems which have 
including impaired glucose 
38 
tolerance, increased serum uric acid, changes in serum lipids 
and impotence, 3 ~ were not detected in our study. 
A study which aval uated a group of 27 elderly persons in a 
nursing home who were on long-term diuretics, found that in 5 
cases there were no clinical notes giving the reason for 
diuretic therapy; in 12 patients the diuretics had been given 
for an initial indication such as hypertension or congestive 
cardiac failure, but the indication had subsequently never 
been re~evaluated; and in the remaining 10 diuretics had been 
given for pedal oedema, likewise without re-assessment. 40 At 
the start of the study, no indications for continuing the 
diuretics could be found in all 27 patients, so the diuretics 
were stopped and subsequent follow-up revealed no need for 
them as long-term therapy. Four patients benefited from the 
cessation of diuretics: in 2 dizziness related to postural 
hypotension was no longer a problem, and 2 others regained 
control of micturi tion. This nursing home study shows that 
even though diuretic therapy appeared to be effective, and 
only 14,8% of patients had side-effects related to diuretics, 
there is a great need to continually re-assess the need for 
all medication if ADR's are to be minimized. This study was 
exceptional regarding their ability to stop all drugs: in a 
study from two geriatric units it was possible to stop 
diuretics in patients admitted to hopsital in only 7 out of 
13 cases, and in 4 they had to subsequently be restarted. 41 
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BETA-ADRENOCEPTOR BLOCKING DRUGS 
The complications of this class of drug that were noted in 
our study are well recognized and relate to their ability to 
block beta-adrenergic receptors. 42 • 43 A review of 
,S-blockers in the elderly has reported that drug handling 
<apart from renal excretion) is not seriously affected by 
advancing age and adverse reactions are not significantly 
more common. 44 However any drug that causes hypotensian 
either by red6cing vascular resistance or by depressing 
cardiac function may cause serious or disastrous consequences 
in the elderly, who are already somewhat volume depleted. 45 
As 8-blockers decrease both vascular resistance and cardiac 
cantractility, their indication 
must be carefully evaluated. 
in the individual patient 
The effect of age on the 
therapeutic effectiveness of ,S-blackers is hard ta predict as 
age may influence not only pharmacokinetics, but also changes 
in the number and sensitivity of ,S-adrenoreceptors. 46 
In our study, 21 patients were an J3-blockers and 5 ADR' s 
presumably due to these agents were found: 160 mg of 
axprenolol daily resulted in one report of intermittent 
claudication, whilst atenolal 50 mg daily was associated with 
two cases of symptomatic bradycardia and two cases of 
congestive cardiac failure. Hydrophilic ,a-blockers Csuch as 
atenolol) are excreted by the kidney, and there is a greater 
risk of toxicity with these agents in the eldery du& to the 
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age-related decline in renal function, particularly in the 
presence of compounding factors such as dehydration which ma.y 
be caused by concurrently prescribed diuretics. Propanolol, 
which is more lipophilic and is cleared by the liver, was 
given to 6 patients in our study without evidence of 
side-effects. However this cannot be seen in isolation: 
propanolol clearance is diminished in elderly subjects47 and 
the Boston Collaborative Drug Surveillance program found a 
12, 4% toxicity rate in patients over the age of 60 years 
given propanolol, compared with a 5,6% incidence of toxicity 
in patients under the age of 50. 48 
CENTRALLY ACTING ANTIHYPERTENSIVE AGENTS 
Methyldopa is effective in lowering blood pressure, is widely 
used, and is well tolerated by many elderly hypertensives. 49 
The major side-effects are centrally mediated, and include 
sedation, dry mouth and postural hypotension. 50 - In our study, 
only 1 out of 28 patients on methyldopa developed a related 
ADR, namely postural hypotension. 
CARDIAC GLYCOSIDES 
Digitalis use in the elderly is widespread51 and in our study 
26 patients (19, 7% of the study population) were receiving 
digoxin; 9 of whom were in docu!!lented atrial fibrillation. 
The others were on digoxin for congestive cardiac failure. 
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There were two cases of digoxin toxicity in the 9 patients 
receiving the drug for atrial fibrillation, resulting in 
reduction of dosage, although serum levels were not done. Of 
the 17 patients on digoxin for cardiac failure, 1 patient 
became nauseous on O, 25 mg daily and this problem resolved 
when digoxin was stopped. In this group, 8 improved on 
their medication <other drugs including digoxin>, 1 did not, 
and the outcome was uncertain in the remainder. Of the 9 
patients on digoxin for atrial fibrillation, 5 improved and 4 
were unsure. 
The findings in our study regarding digoxin reflect in some 
ways the continuing debate regarding the appropriate use of 
this drug. Digoxin has a low therapeutic index and is a 
difficult drug to use in the elderly as underlying diseases 
and multiple-drug use tend to increase the danger of digoxin 
toxicity. 3 ..... This may manifest in an unusual fashion, for 
example, depression or anorexia. Furthermore two-thirds cf 
patients who are digoxin toxic may have blood levels close to 
or within the therapeutic range. 52 
Whilst there is little controversy with regard to the use of 
digoxin in certain supraventricular tachycardias, particul-
arly in controlling the ventricular response rate in atrial 
fibrillation, its routine use in cardiac failure requires 
careful consideration. At least one study has shown that, in 
elderly patients who are in congestive ~eart failure with 
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normal cardiac rythm, 
ventricular ejection 
digoxin clearly 
fraction. 53 Some 
improved their left 
of these patients 
achieved maximal improvement in ejection fraction at serum 
digoxin c::oncentrations of less than 1, 0 ng/ml. However some 
studies have found that there are many patients on digoxin 
who do not benefit from it, 53 • 54 and in a re-evaluation of 
digitalis efficacy Mulrow and colleagues have concluded that 
"elderly patients with stable heart failure who have been 
managed chronically with digoxin may warrant a closely 
monitored trial of withdrawal of digoxin therapy. 1166 In our 
study, one patient who developed digoxin toxicity had the 
drug withdrawn without the development of problems. Two 
patients who were digoxin toxic on O, 25 mg daily tolerated 
0, 125 mg daily without side-effects. It follows that where 
long-term digoxin therapy is needed, it should be used in the 
lowest dose that is effective in a given patient. 
NON-STEROIDAL ANTI-INFLAJ,[],[ATORY DRUGS <NSAIDs> 
It is well recognised that the NSAIDs as a group are 
associated with a high incidence of adverse reactions, and 
many of these are more common and more serious in the 
elderly. 56 • 57 The experience with benaxoprofen, which 
resulted in the death of a number of elderly patients, was 
related to age related pharmacokinetic changes which resulted 
in decreased renal elimination of this drug, with the 
consequent high serum concentrations leading to renal and 
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hepatic failure. 58 The need for caution with NSAIDs is now 
well known, and guidelines for dosage adjustment in the 
elderly are available. 69 Adverse reactions associated with 
NSAID use in the elderly include indigestion, gastric 
ulceration, renal impairment with sodium retention, ankle 
oedema and precipitation of cardiac failure, interference 
with antihypertensive agents, blood dyscrasias, and cognitive 
impairment. 60 • 61 
In our study 33% of the patient sample were receiving NSAIDs. 
Of these 44 patients, four (9%) experienced NSAID related 
ADRs: 75 mg of diclophenac daily resulted in two reports of 
dyspepsia, and 75 mg of indomethacin daily resulted in one 
report of dyspepsia and one of peptic ulceration. Guidelines 
to minimize the occurrence of ADRs from NSAIDs in high risk 
patients have been published. 62 They include: begining 
therapy with the least potent NSAID or other types of 
analgesic agents; the use of an appropriate NSAID in a dose 
that allows for factors such as renal impairment; the 
measurement of baseline serum creatinine 
levels with subsequent repeat monitoring, 
antihypertensive or diuretic medications 




are added; and 
44 
Comments on some frequently prescribed drui?.s that were not 
associated with recorded side-effects in our study 
Benzodiazepines 
Where sedative-hypnotic drugs are required in the elderly, 
benzodiazepines are commonly used63 and are generally safe, 
al though older patients must be monitored closely for the 
development of excessive drowsiness or ataxia as agents with 
long half-lives reach steady-state levels. 6 ~ In one study 
of 257 ambulatory geriatric patients, 36, 1% of their study 
population used benzodiazepines, and the authors concluded 
that "that there was no evidence that any subject had become 
addicted .... it appears that in this age group, prolonged use 
of benzodiazepines at low doses, with the patients regulating 
the quantity, is safe and may be helpful." 65 
The benzodiazepines were the third most frequently prescribed 
drugs in our study, 
morbidity by 37, 1 % 
and were being used without recorded 
of the study population. Of the 49 
prescriptions for benzodiazepines, 24 were for diazepam and 
17 for nitrazepam. Although both of these agents have 
prolonged half-lives in the elderly, 66 all the 
benzodiazepines were used in low dosages and this may 
account for the absence of side-effects in our study. 
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Paracetamol 
Changes in the pharmacokinetics of paracetamol in the elderly 
have been documented, but they are not significant enough to 
require dose adjustment. 2 There is a risk of hepatotoxicity 
when used in supratherapeutic doses, particularly in the 
presence of chronic liver disease, but in therapeutic doses 
paracetamol appears to be a relatively safe analgesic for use 
in the geriatric population. 58 33 of our patients were an 
paracetamol without the appearance of adverse reactions. 
Antacids 
It has been reported that hiatus hernia, gastritis and 
gastric ulcer are more common in the elderly. 67 In a large 
study comprising just over 3 000 elderly ambulatory patients, 
13% of men and nearly 19% of women used antacids. 59 Side-
effects noted included constipation from aluminium containing 
preparations and diarrhoea from calcium carbonate compounds. 
In our study, 28 patients (21,2% of the group studied) were 
receiving regular antacids without obvious side-effects. 
The indications for the antacids appeared to be dyspepsia, or 
hiatus hernia in a few patients. 
receiving antacids were on NSAIDs. 
DISCUSSION 
Thirteen of the patients 
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Drug interactions 
When two or mare drugs are administered concurrently or 
within a reasonable period of each other, the result may be 
indifference, synergism, potentiation, or antagonism.•' This 
may occur because of interactions at a physicochemical, 
pharmacokinetic or phar:macodynamic level. 70 With long-term 
polypharmacy, probably the mast important drug interactions 
are the blunting of the effects of one drug by another <such 
as the antagonism of a diuretic by a NSAID>, and the 
predisposition to the side-effect of one drug by the use of 
another <such as when diuretic induced hypokalemia 
predisposes to digoxin toxicity>. It has been estimated that 
in the ambulatory elderly, about 6% of patients might be 
affected by drug-drug interactions, although in nursing 
homes, with 4 to 9 drugs per patient per day, they may 
account for 22% of all ADRs reported. 69 
In our study, two of the patients who experienced digoxin 
toxicity were also on thiazide diuretics, which could have 
predisposed these patients to the digoxin toxicity. Three 
other patients who 
hypotension related 
experienced dizziness 
to the introduction of 
and postural 
an additional 
anti-hypertensive agent were in fact already on diuretics, 
and therefore the ADR attributed to the additional agent :rnay 
really have reflected a summation of side-effects. Thus, in 
our study, 5 out of 19 ADRs were possible drug-drug 
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interactions <26,3%). Looked at in another way, 3,8~ <5 out 
of 132 patients) of the study population had an ADR which may 
have largely been due ta a drug-drug interaction. 
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CHAPTER FIVE 
CONCLUSION AND RECOMMENDATIONS 
This study has found that degenerative, largely unavoidable 
conditions such as hypertension, congestive cardiac failure, 
ischemic heart disease and musculoskeletal disorders were 
common amongst a group of ambulatory elderly patients, and 
these diseases were managed with a variety of drugs. This 
study contributes to our understanding of polypharmacy in the 
elderly, as it was based on a random group of elderly 
ambulatory patients, and both the benefits (efficacy) and 
adverse effects of drug therapy were evaluated. This differs 
from many other studies of ADRs in the elderly, in which only 
those ADRs resulting in hospital admission were reported. 
Those studies, based on a selected inpatient sample, have not 
permitted an assessment of the incidence of such ADRs 
relative to the population at risk, nor have they permitted 
an evaluation of the benefit that the majority of patients 
might gain through polypharmacy. 
The findings of this study indicate that polypharmacy does, 
in general, appear effective in controlling symptoms or even 
the disease processes in the population studied, and that the 
majority of patients benefitted from the therapeutic 
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intervention. Only a minority of patients experienced an 
ADR, which tended to be relatively benign and reversible on 
discontinuing the offending medication. These findings 
support the observation that "drugs are probably the most 
cost-effective modality of chronic disease management." 71 
At the same time it must be remembered that every patient who 
suffers an adverse drug reaction is unlikely to find much 
consolation in the fact that the statistical majority 
benefi tted. Accordingly, studies such as this attempt to 
identify prescribing practices that are safe and effective, 
and also draw attention to problem areas where the use of 
certain drugs must be particularly carefully evaluated. In 
the previous two chapters, details have been provided of some 
of the drugs that were prescribed most frequently in this 
study group, with particular reference to those agents that 
were associated with side-effects. However, due ta the 
relatively smal 1 numbers of patients studied, the range of 
side-effects found was small, and they are really more of 
relevance as components of a general strategy to minimize 
adverse drug reactions in the elderly. 
Al though pol ypharmacy can be 
an ADR places an onus on 
indications for each drug 
beneficial, the possi bi 1 i ty of 
the 
in 
occasion that it is prescribed. 
may often be an unfortunate 
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a 
prescriber to review the 
given patient on every 
The prescription of a drug 






ill-defined symptoms, and 
for comprehensive assessment 
an 
of 
physical, psychological and social well-being. 
inappropriate 
the patients 
Because it is 
generally easier to prescribe medication, there tends to be 
little enthusiasm for other therapeutic modalities such as 
rehabilitative or environmental intervention. The patient, 
trying to face the deprivations and deal with the demands of 
the aging process, may benefit more from an educator, guide 
and philosopher than from an ill-conceived, 
potentially toxic assortment of pills. 
costly and 
Where it is felt that the use of medication is the most 
appropriate form of treatment, the prescriber needs to be 
well informed about the drugs to 




a knowledge of the 
drug• s likely pharmacokinetics and pharmacodynamics in the 
presence of age and disease, and the possibly altered. 
manifestations of drug toxicity in the elderly patient. 
Fortunately the need for this kind of knowledge is now 
recognised, and research in this field is ongoing. Studies 
such as this one could be extended to farm part of the 
ongoing evaluation of drug therapy in elderly ambulatory 
patients. Information on drug efficacy and the incidence of 
side-effects would be useful as a component in auditing the 
quality of geriatric health care, whilst data on individual 
drug side-effects could assist in maintaining an ongoing 
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. . . 
awareness of potential pit-falls in drug treatment of the 
elderly. A real-time prospective entry of patient 
prescriptions and relevant clinical data into a computer 
data base would not only ensure the collection of a large 
amount of data which could be of benefit in the detection of 
previously unsuspected ADRs and drug-drug interactions, but 
would also screen prescriptions for known drug-disease and 
drug-drug interactions. 
The use of modern technology is however only an aid, and not 
a substitute far a knowledgeable physician and the use of 
sound clinical judgment in the effective management of 





drug therapy in the aged 
in a 10 page report by 
have been 
an expert 
committee of the Royal College of Physicians of Londan. 72 In 
this report the need far careful clinical assessment, the 
simplification of the dose and drug regime as far as 
possible, and good communication between the patient and 
members of the health care team are emphasized. These 
points, together with a sound appreciation of clinical 
pharmacology in the elderly, provide a basis far the more 
effective and safer use of drugs in the older patient. 
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Appendix J 
GERIATRIC POLYPHARMACY PROJECT 
DATA COLLECTION SHEET 
A. Patient Folder No. 
B. Age: 
C. Race: D. Sex: 
E. Number of disease processes being treated: 











i 2 SEP ·1198P 
' d 
G. Length of time (in months) patient has been on this identical prescription: 
·H. If less than six months' indicate reasons for change eg. side effects, 
therapeutic failure, appearance of new disease process: 
(free text) 
I. If side-effects (drug reactions) are the answer to question (H) indicate 
responsible drugs. Indicate whether drug reaction (DR) or drug-drug 






Comments: eg. 6/60, 12/60 shows low 
potassium 
J. Does the patient's present prescription appear to be therapeutically 
effective? 
YES / NO / UNSURE. 
